Products for Research Use Only
RegisterLogin

Antitumor agent-145

CAT: 0804-HY-162348Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-162348Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Antitumor agent-145 (Compound Ir5) is a tumor inhibitor with remarkable fluorescence and mitochondrial targeting, which exerts anti-cancer effects by inducing necroptosis and activating the necroptosis-related immune response[1].
CAS Number
2983120-65-4
UNSPSC
12352005
Target
Necroptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-145.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C2=CC=CC=C2C=C1)/C=[N]3N=C(N(C)C)[S-][Ir+3]\345([N]6=C(C7=C(C=C6)C=CC=C7)C8=CC=CC=[C-]85)[N]9=C(C%10=C(C=C9)C=CC=C%10)C%11=CC=CC=[C-]%114
Molecular Formula
C44H34IrN5OS
Molecular Weight
873.06
References & Citations
[1]Li, Wenjuan et al. “Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium (III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response.” Journal of medicinal chemistry vol. 67,5 (2024) : 3843-3859.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-162128Antitumor agent-130
HY-161425Antitumor agent-149
HY-155034Antitumor agent-102
HY-151292Antitumor agent-74
HY-116447-01Antitumor agent-159
HY-149717Antitumor agent-122
HY-115948Antitumor agent-46
HY-152537Antitumor agent-84
HY-128776Antitumor agent-19
HY-163691Antitumor agent-163

Alternative Products

CatalogName
T85706-01Antitumor agent-145
M26058-01Antitumor agent-19
T10342-01Antitumor agent-2
T211211-01Antitumor agent-203
T209984-01Antitumor agent-156
T209806-01Antitumor agent-151
T209096-01Antitumor agent-131
T206452-01Antitumor agent-200
T205444-01Antitumor agent-198
T200846-01Antitumor agent-188

Popular Products